Cara Therapeutics reported $0 in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acelrx Pharmaceuticals ACRX:US USD 7.89M 2M
Depomed DEPO:US USD 68.16M 7M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Horizon Pharma HZNP:US USD 2.57B 1.85M
JAZZ PHA JAZZ:US USD 5.73B 294.18M
Neurocrine Biosciences NBIX:US USD 169.2M 200K
Pacira Pharmaceuticals PCRX:US USD 747.87M 7.78M
Revance Therapeutics RVNC:US USD 388.28M 7.82M
Supernus Pharmaceuticals SUPN:US USD 401.44M 529K
Teva Pharmaceutical Industries TEVA:US USD 21.27B 816M